| Literature DB >> 26515424 |
Melanie Gonsior1, Agnes Mühlenweg1, Marcel Tietzmann1, Saskia Rausch1, Annette Poch1, Roderich D Süssmuth2.
Abstract
Feglymycin, a peptide antibiotic produced by Streptomyces sp. DSM 11171, consists mostly of nonproteinogenic phenylglycine-type amino acids. It possesses antibacterial activity against methicillin-resistant Staphylococcus aureus strains and antiviral activity against HIV. Inhibition of the early steps of bacterial peptidoglycan synthesis indicated a mode of action different from those of other peptide antibiotics. Here we describe the identification and assignment of the feglymycin (feg) biosynthesis gene cluster, which codes for a 13-module nonribosomal peptide synthetase (NRPS) system. Inactivation of an NRPS gene and supplementation of a hydroxymandelate oxidase mutant with the amino acid l-Hpg proved the identity of the feg cluster. Feeding of Hpg-related unnatural amino acids was not successful. This characterization of the feg cluster is an important step to understanding the biosynthesis of this potent antibacterial peptide.Entities:
Keywords: antibiotics; cell-wall biosynthesis inhibitor; dihydroxyphenylglycine; hydroxyphenylglycine; nonribosomal peptide synthesis; peptides
Mesh:
Substances:
Year: 2015 PMID: 26515424 DOI: 10.1002/cbic.201500432
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164